Reagents and instruments for immunology, cell biology and molecular biology.
Log in
Forgot your password?
Open account
fr
en
es
de
it
pt
nl
0
0
View cart
Catalog
Research areas
Diagnostic
Custom services
CRO services
Technical resources
Special offer
Contact
Reagents and instruments for immunology, cell biology and molecular biology.
Search result : 16 product found
Refine your search :
RUO
CE / IVD
Conjugate (1)
Unconjugated
16
Class (1)
Inhibitor/Antagonist/Agonist
APPLY FILTERS
REINITIALIZE
SHARE THIS SEARCH
COPIED
10
20
50
100
200
500
Cat#
Description
Cond.
Price Bef. VAT
orb1910546-1g
FY-21 is a selective inhibitor of LSD1.
1g
orb1910546-100mg
FY-21 is a selective inhibitor of LSD1.
100mg
orb1910546-250mg
FY-21 is a selective inhibitor of LSD1.
250mg
orb1909814-250mg
Corin is a dual inhibitor of histone lysine specific demethylase (LSD1) and histone deacetylase (HDAC), with a Ki(inact) of 110 nM for LSD1 and an IC50 of 147 nM for HDAC1. [[1808113-09-8]]
250mg
orb1909814-1g
Corin is a dual inhibitor of histone lysine specific demethylase (LSD1) and histone deacetylase (HDAC), with a Ki(inact) of 110 nM for LSD1 and an IC50 of 147 nM for HDAC1. [[1808113-09-8]]
1g
orb1909814-100mg
Corin is a dual inhibitor of histone lysine specific demethylase (LSD1) and histone deacetylase (HDAC), with a Ki(inact) of 110 nM for LSD1 and an IC50 of 147 nM for HDAC1. [[1808113-09-8]]
100mg
orb1910252-1g
J 3-54 , also known as LSD1-IN-24, is a selective LSD1 inhibitor with IC50 = 0.247 μM. VUN34592 can mediate the expression of PD-L1, enhance T cell killing response, and can be used in cancer research. [[4734-59-2]]
1g
orb1910252-100mg
J 3-54 , also known as LSD1-IN-24, is a selective LSD1 inhibitor with IC50 = 0.247 μM. VUN34592 can mediate the expression of PD-L1, enhance T cell killing response, and can be used in cancer research. [[4734-59-2]]
100mg
orb1910252-250mg
J 3-54 , also known as LSD1-IN-24, is a selective LSD1 inhibitor with IC50 = 0.247 μM. VUN34592 can mediate the expression of PD-L1, enhance T cell killing response, and can be used in cancer research. [[4734-59-2]]
250mg
orb1910516-1g
HDAC-IN-57 is an orally active inhibitor of histone deacetylases (HDAC), with IC50s of 2.07 nM, 4.71 nM, 2.4 nM and 107 nM for HDAC1, HDAC2, HDAC6, HDAC8, respectively. HDAC-IN-57 can inhibits LSD1, with IC50 of 1.34 μΜ. HDAC-IN-57 induces apoptosis, and has anti-tumor activity[1]. [[2716217-79-5]]
1g
orb1910516-100mg
HDAC-IN-57 is an orally active inhibitor of histone deacetylases (HDAC), with IC50s of 2.07 nM, 4.71 nM, 2.4 nM and 107 nM for HDAC1, HDAC2, HDAC6, HDAC8, respectively. HDAC-IN-57 can inhibits LSD1, with IC50 of 1.34 μΜ. HDAC-IN-57 induces apoptosis, and has anti-tumor activity[1]. [[2716217-79-5]]
100mg
orb1910516-250mg
HDAC-IN-57 is an orally active inhibitor of histone deacetylases (HDAC), with IC50s of 2.07 nM, 4.71 nM, 2.4 nM and 107 nM for HDAC1, HDAC2, HDAC6, HDAC8, respectively. HDAC-IN-57 can inhibits LSD1, with IC50 of 1.34 μΜ. HDAC-IN-57 induces apoptosis, and has anti-tumor activity[1]. [[2716217-79-5]]
250mg
217521-10mg
LSD1 Inhibitor IV, RN-1,HCl (2-(1R,2S)-2-(4-(Benzyloxy)phenyl)cyclopropylamino)-1-(4-methylpiperazin-1-yl)ethanone, HCl, Lysine (K)-Specific Demethylase Inhibitor IV,RN-1,HCl, BHC110 Inhibitor IV, KDM1 Inhibitor IV, MOA Inhibitor III)
10mg
MBS3602865
LSD1 inhibitor 24
onrequest
217520-10mg
LSD1 Inhibitor III, CBB1007 (Histone Lysine Demethylase Inhibitor V, CBB1007, KDM1 Inhibitor III, CBB1007, (Methyl-3-(4-(4-carbamimidoylbenzoyl)piperazine-1-carbonyl)-5-((4-carbamimidoylpiperazin-1-yl)methyl)benzoate, BHC110 Inhibitor III, Lysine Specific Demethylase Inhibitor VI)
10mg
orb1818682-100mg
T-448
100mg
‹
›